# Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache

> **NCT03112720** · PHASE3 · TERMINATED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 8 (actual)

## Conditions studied

- Postdural Puncture Headache

## Interventions

- **DEVICE:** Epidural Blood Patch
- **DRUG:** Sphenopalatine Ganglion Block

## Key facts

- **NCT ID:** NCT03112720
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** no enrollment after covid pandemic
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03112720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03112720, "Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03112720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*